Renal SABR: Implementation of A New Standard of Care
- Author(s)
- Correa, RJM; Ali, M; Tan, VS; Siva, S;
- Journal Title
- International Journal of Radiation Oncology, Biology, Physics
- Publication Type
- Online publication before print
- Abstract
- Stereotactic ablative radiotherapy (SABR), or stereotactic body radiotherapy (SBRT), has emerged as a new standard of care treatment option for localized renal cell carcinoma {RCC). Here we present an accessible, high-yield guide to implementing SABR for RCC. A Q&A format was selected for ease of navigation. Common queries around treatment indications and patient selection to SABR planning, delivery, and follow-up are addressed. Succinct, quick-hit answers are supported by relevant, contemporary literature.
- Keywords
- Renal cell carcinoma; stereotactic ablative radiotherapy
- Department(s)
- Radiation Oncology
- Publisher's Version
- https://doi.org/10.1016/j.ijrobp.2025.12.046
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2026-01-20 12:06:14
Last Modified: 2026-01-20 12:06:31